Ipatasertib
| CAS No. | 1001264-89-6 |
|---|---|
| MDL No. | MFCD22124514 |
| MF | C24H32ClN5O2 |
| MW | 458.00 |
| InChI Key | GRZXWCHAXNAUHY-NSISKUIASA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
(2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]-1-piperazinyl]-3-(propan-2-ylamino)-1-propanone is a N-arylpiperazine.
| CAS No. | 1001264-89-6 |
|---|---|
| Product Name | Ipatasertib |
Biological Targets
AKT2·AKT3·AKT1
Associated Conditions
prostate cancer·metastatic prostate cancer·breast cancer·ovarian carcinoma·gastric cancer·
* The information provided here is compiled from public sources and is for reference only.
